Related Experiment Video
Updated: Aug 8, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions
Published on: October 30, 2016
Regulation of natural killer cell activation: implementation for the control of tumor metastasis
Abstract:
The cellular interactions that regulate natural killer (NK) cell-mediated cytotoxicity and antimetastatic activity following treatment with biological response modifiers (BRM) were studied. The transient activation of NK cells by a single injection of Corynebacterium parvum is followed by a refractory period during which a second injection of BRM fails to stimulate the already depressed NK cell activity. During this hyporesponsive period, the in vivo NK cell-dependent BRM-induced antimetastatic activity is markedly reduced and cannot be enhanced by multiple injections of BRM. A correlation exists between the generation of hyporesponsiveness to NK cell activation and the activation of suppressor macrophages by C. parvum. BRM that selectively activate NK cells without subsequently activating suppressor macrophages do not induce hyporesponsiveness to further activation of NK cells in vivo and, when given in multiple injections, retain the ability to inhibit hematogenous tumor metastasis.
Insights
Biological response modifiers (BRM) transiently activate natural killer (NK) cells. Subsequent NK cell hyporesponsiveness, linked to suppressor macrophage activation, impairs antimetastatic activity.
Area of Science:
- Immunology
- Cancer Research
- Cellular Biology
Background:
- Natural killer (NK) cells are crucial for anti-metastatic activity.
- Biological response modifiers (BRM) can modulate NK cell function.
- Understanding NK cell regulation by BRM is vital for cancer therapy.
Purpose of the Study:
- To investigate the cellular interactions governing NK cell cytotoxicity and antimetastatic effects induced by BRM.
- To elucidate the mechanisms behind NK cell hyporesponsiveness following BRM treatment.
- To identify BRM strategies that maintain NK cell activation for sustained anti-tumor effects.
Main Methods:
- Studied cellular interactions regulating NK cell-mediated cytotoxicity and antimetastatic activity.
- Administered Corynebacterium parvum (C. parvum) as a BRM to induce NK cell activation and subsequent hyporesponsiveness.
- Investigated the role of suppressor macrophages in NK cell hyporesponsiveness.
- Evaluated the efficacy of BRM that selectively activate NK cells without activating suppressor macrophages.
Main Results:
- A single C. parvum injection transiently activates NK cells, followed by a refractory period with depressed NK cell activity.
- During hyporesponsiveness, BRM-induced antimetastatic activity is significantly reduced and not enhanced by multiple BRM injections.
- NK cell hyporesponsiveness correlates with C. parvum-induced suppressor macrophage activation.
- BRM selectively activating NK cells without suppressor macrophage activation prevent hyporesponsiveness and maintain anti-metastatic potential.
Conclusions:
- NK cell activation by certain BRM is transient and can lead to hyporesponsiveness.
- Suppressor macrophages play a key role in mediating this BRM-induced NK cell hyporesponsiveness.
- BRM that avoid suppressor macrophage activation offer a promising strategy for sustained NK cell-mediated anti-metastatic therapy.
Related Concept Videos
Mitogens and the Cell Cycle
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy

